Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
NYU Langone Health
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
PETHEMA Foundation